Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Hikma Stands Firm On Supply As It Scoffs At Latest Amarin Lawsuit
Motion To Dismiss Filed; Advair Expectations Disclosed
Jan 14 2021
•
By
Dean Rudge
Hikma has so far taken a Vascepa market share of around 10%-12% following market entry in November. • Source: Shutterstock
More from Generics
More from Products